MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/07853890.2025.2561224

Медицинская библиотека · Annals of medicine · 2025

The value of plasma presepsin as a diagnostic and prognostic biomarker for febrile neutropenia in children.

Liang Jianbo, Luo Jinmei, Li Gen, Li Laisheng, Wu Juehui

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Febrile neutropenia (FN) is a prevalent infectious complication in paediatric cancer patients undergoing anticancer treatment. Presepsin is a reliable biomarker for sepsis; however, its clinical value in the context of paediatric FN remains unclear. This study aimed to evaluate the efficacy of presepsin in the entire course of paediatric patients with FN.

METHODS

In this prospective study, 108 paediatric patients with haematological tumours complicated with neutropenia were recruited, of whom 23 had febrile neutropenia. Blood samples were collected daily, and four inflammation biomarkers, presepsin, procalcitonin (PCT), interleukin-6 (IL-6) and C-reactive protein (CRP), were analyzed. Clinical and laboratory parameters were collected, and the diagnostic and prognostic value of biomarkers for FN was assessed.

RESULTS

The concentrations of presepsin, PCT, IL-6 and CRP were prospectively measured in 57 FN episodes in 23 cases of malignant haematological diseases in children. The concentrations of presepsin, PCT and CRP were significantly elevated 72 h before onset compared to those in the control group. Only the concentration of presepsin at FN onset was significantly higher than 72 h before FN onset. The area under the curve (AUC) of presepsin, PCT, IL-6 and CRP for FN diagnosis 24 h before FN onset were 0.9118, 0.8214, 0.9052 and 0.8286, respectively. For prognosis, the levels of presepsin were consistently and significantly higher at every time point in patients with unfavourable outcomes than in those with favourable outcomes.

CONCLUSION

Presepsin demonstrated the best performance in both the early diagnosis and prognosis assessment of FN, indicating that it is a reliable biomarker for managing the entire FN process. Close monitoring of presepsin may enable earlier intervention for FN, reducing the occurrence of adverse events caused by infection.

Для цитирования: Liang Jianbo, Luo Jinmei, Li Gen, Li Laisheng, Wu Juehui. The value of plasma presepsin as a diagnostic and prognostic biomarker for febrile neutropenia in children.. Annals of medicine. 2025. DOI: 10.1080/07853890.2025.2561224.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.